Industry Update: The latest developments in therapeutic delivery

    loading  Checking for direct PDF access through Ovid


The present industry update covers the period 16 November–31 December 2012, with information sourced from company press releases. In this period, Alexza Pharmaceuticals (CA, USA) obtained long-awaited US FDA approval for the inhaled treatment of agitation, while European marketing approval was granted for CeQur's insulin delivery device. In clinical trial news, Phosphagenics look to commence with Phase III clinical trials for an opiod transdermal patch, and Aegis Therapeutics (CA, USA) were awarded a US patent for absorption-enhancing self-assembling aqueous hydrogels. Other developments have seen restructuring at QLT, while Pfizer (NY, USA) have completed the acquisition of NextWave Pharmaceuticals.

Related Topics

    loading  Loading Related Articles